R. Iwase1, Y. Suzuki2, E. Yamanouchi3, H. Odaira2, K. Yanaga1 1The Jikei University School Of Medicine,Department Of Surgery,Minato-ku, TOKYO, Japan 2International University Of Health And Welfare Hospital,Department Of Surgery,Nasushiobara, TOCHIGI, Japan 3International University Of Health And Welfare Hospital,Department Of Radiology,Nasushiobara, TOKYO, Japan
Introduction:
The management of gastric cancer causing pyloric stenosis and gastric dilatation must include decompression of the stomach and nutritional support. Percutaneous transesophageal gastrotubing (PTEG) is an effective technique for either gastric decompression or enteral nutrition. Here, we investigated the efficacy and safety of double PTEG, i.e., PTEG for both purposes for patients with gastric cancer.
Methods:
Eleven patients with pyloric stenosis due to gastric cancer were admitted to our hospital between January 2015 and March 2017 and enrolled in this study. Each patient underwent double PTEG as soon as possible. After double PTEG tubes were placed, gastric decompression was started immediately and enteral nutrition was started within one day. Feeding and decompression through the double tubes were continued until the day before operation. Using data from these patients, we investigated the efficacy and safety of double PTEG.
Results:
Double PTEG was performed successfully in all patients and no critical adverse effects were observed. Of the eleven patients, eight underwent radical or palliative resection. Decompression of the stomach was achieved and nutritional parameters improved significantly after the double PTEG in all patients.
Conclusion:
Double PTEG is a safe and effective management technique for patients with pyloric stenosis and gastric dilatation due to gastric cancer.